Literature DB >> 15073461

The disproportionate impact of hypertensive cardiovascular disease in African Americans: getting to the heart of the issue.

Kenneth A Jamerson1.   

Abstract

The prevalence of hypertension in African Americans is among the highest in the world. Persons in this group develop hypertension at a younger age than non-African Americans and develop more severe complications, including stroke, cardiovascular disease, and renal failure. The factors that impart this high risk to this population remain poorly understood and, undoubtedly, environmental factors overshadow genetic predisposition. While identifying the pathophysiologic and environmental factors that contribute to ethnic disparity in disease is important, finding a long-term solution is crucial. Steps that can have an important impact on health outcomes of African Americans are presently available. Awareness of ethnicity as a risk factor for hypertension can allow health care providers to identify persons who are likely to benefit most from early, aggressive intervention. Modifiable factors such as smoking, diet, and sedentary lifestyle, as well as undertreatment of hypertension by physicians, can be targeted immediately.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15073461      PMCID: PMC8109647          DOI: 10.1111/j.1524-6175.2004.03563.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  21 in total

1.  Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks.

Authors:  Janice G Douglas; George L Bakris; Murray Epstein; Keith C Ferdinand; Carlos Ferrario; John M Flack; Kenneth A Jamerson; Wendell E Jones; Julian Haywood; Randall Maxey; Elizabeth O Ofili; Elijah Saunders; Ernesto L Schiffrin; Domenic A Sica; James R Sowers; Donald G Vidt
Journal:  Arch Intern Med       Date:  2003-03-10

2.  The prevalence of hypertension in seven populations of west African origin.

Authors:  R Cooper; C Rotimi; S Ataman; D McGee; B Osotimehin; S Kadiri; W Muna; S Kingue; H Fraser; T Forrester; F Bennett; R Wilks
Journal:  Am J Public Health       Date:  1997-02       Impact factor: 9.308

3.  Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

4.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Authors:  Jackson T Wright; George Bakris; Tom Greene; Larry Y Agodoa; Lawrence J Appel; Jeanne Charleston; DeAnna Cheek; Janice G Douglas-Baltimore; Jennifer Gassman; Richard Glassock; Lee Hebert; Kenneth Jamerson; Julia Lewis; Robert A Phillips; Robert D Toto; John P Middleton; Stephen G Rostand
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

5.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

Authors:  L Y Agodoa; L Appel; G L Bakris; G Beck; J Bourgoignie; J P Briggs; J Charleston; D Cheek; W Cleveland; J G Douglas; M Douglas; D Dowie; M Faulkner; A Gabriel; J Gassman; T Greene; Y Hall; L Hebert; L Hiremath; K Jamerson; C J Johnson; J Kopple; J Kusek; J Lash; J Lea; J B Lewis; M Lipkowitz; S Massry; J Middleton; E R Miller; K Norris; D O'Connor; A Ojo; R A Phillips; V Pogue; M Rahman; O S Randall; S Rostand; G Schulman; W Smith; D Thornley-Brown; C C Tisher; R D Toto; J T Wright; S Xu
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

6.  Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

7.  Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial.

Authors:  L P Svetkey; D Simons-Morton; W M Vollmer; L J Appel; P R Conlin; D H Ryan; J Ard; B M Kennedy
Journal:  Arch Intern Med       Date:  1999-02-08

8.  Excess mortality in Harlem.

Authors:  C McCord; H P Freeman
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

9.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

10.  Deaths: leading causes for 2000.

Authors:  Robert N Anderson
Journal:  Natl Vital Stat Rep       Date:  2002-09-16
View more
  14 in total

Review 1.  African Americans with asthma: genetic insights.

Authors:  Kathleen C Barnes; Audrey V Grant; Nadia N Hansel; Peisong Gao; Georgia M Dunston
Journal:  Proc Am Thorac Soc       Date:  2007-01

2.  A genetic polymorphism in the CYP19A1 gene and the risk of hypertension among midlife women.

Authors:  Ayelet Ziv-Gal; Lisa Gallicchio; Susan R Miller; Howard A Zacur; Jodi A Flaws
Journal:  Maturitas       Date:  2011-11-21       Impact factor: 4.342

3.  Night blood pressure responses to atenolol and hydrochlorothiazide in black and white patients with essential hypertension.

Authors:  Arlene B Chapman; George Cotsonis; Vishal Parekh; Gary L Schwartz; Yan Gong; Kent R Bailey; Stephen T Turner; John G Gums; Amber L Beitelshees; Rhonda Cooper-DeHoff; Eric Boerwinkle; Julie A Johnson
Journal:  Am J Hypertens       Date:  2013-07-25       Impact factor: 2.689

Review 4.  Executive summary of the African-American Initiative.

Authors:  Clyde W Yancy
Journal:  MedGenMed       Date:  2007-02-08

5.  Weight status and high blood pressure among low-income African American men.

Authors:  Marino A Bruce; Bettina M Beech; Christopher L Edwards; Mario Sims; Isabel Scarinci; Keith E Whitfield; Keon Gilbert; Errol D Crook
Journal:  Am J Mens Health       Date:  2010-10-11

6.  Racial disparity in blood pressure: is vitamin D a factor?

Authors:  Kevin Fiscella; Paul Winters; Dan Tancredi; Peter Franks
Journal:  J Gen Intern Med       Date:  2011-04-21       Impact factor: 5.128

Review 7.  Genetic determinants and ethnic disparities in sepsis-associated acute lung injury.

Authors:  Kathleen C Barnes
Journal:  Proc Am Thorac Soc       Date:  2005

Review 8.  Genetics of transfusion recipient alloimmunization: can clues from susceptibility to autoimmunity pave the way?

Authors:  Zohreh Tatari-Calderone; Naomi L C Luban; Stanislav Vukmanovic
Journal:  Transfus Med Hemother       Date:  2014-11-17       Impact factor: 3.747

9.  Opportunities for the Advanced Practice Nurse to Enhance Hypertension Knowledge and Self-management Among African American Women.

Authors:  Lenette M Jones; Marie-Anne S Rosemberg; Kathy D Wright
Journal:  Clin Nurse Spec       Date:  2017 Nov/Dec       Impact factor: 1.067

10.  Understanding social disparities in hypertension prevalence, awareness, treatment, and control: the role of neighborhood context.

Authors:  Jeffrey D Morenoff; James S House; Ben B Hansen; David R Williams; George A Kaplan; Haslyn E Hunte
Journal:  Soc Sci Med       Date:  2007-07-20       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.